National Human Genome Research Institute; Notice of Closed Meetings, 67495 [05-22076]
Download as PDF
<![CDATA[
67495
Federal Register / Vol. 70, No. 214 / Monday, November 7, 2005 / Notices
Estimated
number of
respondents
Type of respondents
Estimated
number of responses per
respondent
Average burden
hours per
response
Estimated total
annual burden
hours requested
124
.33
Next-of-kin ....................................................................................................
Physician’s Office Staff ................................................................................
1,483
4
1
1
.0835
.0835
Total ......................................................................................................
87,273
........................
..........................
The annualized cost burden to
respondents is $290,230. There are no
annual Capital Costs, Operating Costs
and/or Maintenance Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection is necessary for the
proper performance of the function of
the agency, including whether the
information will have practical utility;
(2) evaluate the accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) enhance the
quality, utility, and clarity of the
information to be collected; and (4)
minimize the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
For Further Information Contact: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Linda Pottern,
Project Officer, Women’s Health
Initiative Program Office, National
Institutes of Health, 6701 Rockledge
Drive, 2 Rockledge Centre, Suite 8204,
MSC 7935, Bethesda, MD 20892–7935,
or call 301–402–2900 or E-mail your
request, including your address to:
potternl@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60-days of the date of
this publication.
Dated: October 28, 2005.
Jacques Rossouw,
NHLBI, WHI Project Officer, National
Institutes of Health.
[FR Doc. 05–22078 Filed 11–4–05; 8:45 am]
BILLING CODE 4140–01–P
VerDate Aug<31>2005
16:38 Nov 04, 2005
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, SEP (ZHG1 HGR N J1).
Date: November 10, 2005.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ken D. Nakamura, PhD,
Scientific Review Administrator, Scientific
Review Branch, National Human Genome
Research Institute, National Institutes of
Health, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, 301–402–0838.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, Design and Analysis RFA.
Date: December 5–6, 2005.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Rudy O. Pozzatti, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Human Genome
Research Institute, National Institutes of
Health, Bethesda, MD 20892, 301 402–0838.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
18,319
Dated: October 26, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–22076 Filed 11–04–05; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Program
Project.
Date: December 1, 2005.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Mark Swieter, PhD, Chief,
Training and Special Projects Review Branch,
Office of Extramural Affiars, National
Institute on Drug Abuse, NIH, DHHS, 6101
Executive Boulevard, Suite 220, Bethesda,
MD 20892–8401, (301) 435–1389,
ms80x@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878; 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 70, Number 214 (Monday, November 7, 2005)]
[Notices]
[Page 67495]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-22076]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel, SEP (ZHG1 HGR N J1).
Date: November 10, 2005.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5635 Fishers Lane,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ken D. Nakamura, PhD, Scientific Review
Administrator, Scientific Review Branch, National Human Genome
Research Institute, National Institutes of Health, 5635 Fishers
Lane, Suite 4076, MSC 9306, Rockville, MD 20852, 301-402-0838.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel, Design and Analysis RFA.
Date: December 5-6, 2005.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Rudy O. Pozzatti, PhD, Scientific Review
Administrator, Office of Scientific Review, National Human Genome
Research Institute, National Institutes of Health, Bethesda, MD
20892, 301 402-0838.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: October 26, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-22076 Filed 11-04-05; 8:45am]
BILLING CODE 4140-01-M
